AdaptHealth Corp. (NASDAQ:AHCO) Receives Consensus Recommendation of "Hold" from Brokerages

AdaptHealth Corp. (NASDAQ:AHCO - Get Free Report) has been assigned an average recommendation of "Hold" from the seven ratings firms that are covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company. The average 12 month price target among analysts that have covered the stock in the last year is $12.10.

AHCO has been the topic of several analyst reports. Truist Financial boosted their price target on shares of AdaptHealth from $11.00 to $13.00 and gave the stock a "buy" rating in a research report on Wednesday, February 28th. Royal Bank of Canada restated an "outperform" rating and issued a $13.00 price target on shares of AdaptHealth in a research note on Monday, March 4th. Jefferies Financial Group cut AdaptHealth from a "buy" rating to a "hold" rating and dropped their price objective for the stock from $14.50 to $8.00 in a research note on Monday, January 8th. Finally, UBS Group raised their target price on shares of AdaptHealth from $9.00 to $13.00 and gave the company a "buy" rating in a research note on Wednesday, February 28th.

Insider Activity at AdaptHealth

In other AdaptHealth news, major shareholder James E. Flynn sold 182,607 shares of the company's stock in a transaction on Monday, March 11th. The shares were sold at an average price of $11.02, for a total value of $2,012,329.14. Following the transaction, the insider now directly owns 11,643,769 shares in the company, valued at $128,314,334.38. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other news, major shareholder James E. Flynn sold 182,607 shares of the stock in a transaction that occurred on Monday, March 11th. The stock was sold at an average price of $11.02, for a total transaction of $2,012,329.14. Following the transaction, the insider now owns 11,643,769 shares in the company, valued at $128,314,334.38. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, major shareholder James E. Flynn sold 52,487 shares of the business's stock in a transaction on Friday, March 8th. The shares were sold at an average price of $10.93, for a total value of $573,682.91. Following the completion of the sale, the insider now owns 11,826,376 shares of the company's stock, valued at $129,262,289.68. The disclosure for this sale can be found here. 13.60% of the stock is owned by company insiders.

Institutional Trading of AdaptHealth

Several hedge funds and other institutional investors have recently bought and sold shares of the business. SG Americas Securities LLC acquired a new stake in shares of AdaptHealth in the third quarter valued at approximately $350,000. Oak Thistle LLC acquired a new stake in shares of AdaptHealth during the 3rd quarter worth $94,000. Simplicity Solutions LLC acquired a new position in AdaptHealth in the third quarter valued at about $315,000. Commonwealth Equity Services LLC lifted its holdings in shares of AdaptHealth by 28.6% during the 3rd quarter. Commonwealth Equity Services LLC now owns 41,482 shares of the company's stock worth $377,000 after acquiring an additional 9,214 shares during the period. Finally, Raymond James & Associates acquired a new stake in shares of AdaptHealth during the 3rd quarter worth approximately $101,000. Institutional investors and hedge funds own 82.67% of the company's stock.

AdaptHealth Stock Up 1.7 %

NASDAQ AHCO traded up $0.17 during trading on Monday, hitting $10.13. The stock had a trading volume of 986,267 shares, compared to its average volume of 1,081,514. AdaptHealth has a 12 month low of $6.37 and a 12 month high of $15.37. The company has a debt-to-equity ratio of 1.44, a quick ratio of 1.00 and a current ratio of 1.21. The company's 50-day moving average price is $10.10 and its two-hundred day moving average price is $8.46. The company has a market capitalization of $1.35 billion, a PE ratio of -1.91, a P/E/G ratio of 0.65 and a beta of 1.02.

AdaptHealth (NASDAQ:AHCO - Get Free Report) last posted its quarterly earnings data on Tuesday, February 27th. The company reported $0.64 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.20 by $0.44. AdaptHealth had a negative net margin of 21.21% and a positive return on equity of 8.84%. The company had revenue of $858.23 million for the quarter, compared to the consensus estimate of $825.94 million. As a group, sell-side analysts forecast that AdaptHealth will post 0.88 EPS for the current year.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.